Value of an Online PI-RADS V2.1 Score Calculator for Assessment of Prostate MRI

Overview

Journal Eur J Radiol Open

Specialty Radiology

Date 2021 Mar 8

PMID 33681427

Citations 5

Authors

Borna K Barth

Katharina Martini

Stephan M Skawran

Florian A Schmid

Niels J Rupp

Laura Zuber

Olivio F Donati

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the value of a browser-based PI-RADS Score Calculator (PCalc) compared to MRI reporting using the official PI-RADS v2.1 document (PDoc) for non-specialized radiologists in terms of reporting efficiency, interrater agreement and diagnostic accuracy for detection of clinically significant prostate cancer (PCa).

Methods: Between 09/2013 and 04/2015, 100 patients (median age, 64.8; range 47.5-78.2) who underwent prostate-MRI at a 3 T scanner and who received transperineal prostate mapping biopsy within <6 months were included in this retrospective study. Two non-specialized radiology residents (R1, R2) attributed a PI-RADS version 2.1 score for the most suspect (i. e. index) lesion (i) using the original PI-RADS v2.1 document only and after a 6-week interval (ii) using a browser-based PCalc. Reading time was measured. Reading time differences were assessed using Wilcoxon signed rank test. Intraclass-correlation Coefficient (ICC) was used to assess interrater agreement (IRA). Parameters of diagnostic accuracy and ROC curves were used for assessment of lesion-based diagnostic accuracy.

Results: Cumulative reading time was 32:55 (mm:ss) faster when using the PCalc, the difference being statistically significant for both readers (p < 0.05). The difference in IRA between the image sets (ICC 0.55 [0.40, 0.68]) and 0.75 [0.65, 0.82] for the image set with PDoc and PCalc, respectively) was not statistically significant. There was no statistically significant difference in lesion-based diagnostic accuracy (AUC 0.83 [0.74, 0.92] and 0.82 [95 %CI: 0.74, 0.91]) for images assessed with PDoc as compared to PCalc (AUC 0.82 [0.74, 0.91] and 0.74 [95 %CI: 0.64, 0.83]) for R1 and R2, respectively.

Conclusion: Non-specialized radiologists may increase reading speed in prostate MRI with the help of a browser-based PI-RADS Score Calculator compared to reporting using the official PI-RADS v2.1 document without impairing interreader agreement or lesion-based diagnostic accuracy for detection of clinically significant PCa.

Citing Articles

A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score.

Chen Z, Zhang J, Jin D, Wei X, Qiu F, Wang X BMC Cancer. 2023; 23(1):1138.

PMID: 37996859 PMC: 10668430. DOI: 10.1186/s12885-023-11306-2.

Machine learning-based analysis of a semi-automated PI-RADS v2.1 scoring for prostate cancer.

Singh D, Kumar V, Das C, Singh A, Mehndiratta A Front Oncol. 2022; 12:961985.

PMID: 36505875 PMC: 9730331. DOI: 10.3389/fonc.2022.961985.

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3.

Huang C, Qiu F, Jin D, Wei X, Chen Z, Wang X Front Oncol. 2022; 12:908956.

PMID: 35860546 PMC: 9289138. DOI: 10.3389/fonc.2022.908956.

Structured reporting in radiologic education - Potential of different PI-RADS versions in prostate MRI controlled by in-bore MR-guided biopsies.

Garmer M, Karpienski J, Groenemeyer D, Wagener B, Kamper L, Haage P Br J Radiol. 2021; 95(1131):20210458.

PMID: 34914538 PMC: 8978241. DOI: 10.1259/bjr.20210458.

Inter-observer and intra-observer agreement of Bosniak classification of cystic renal masses: Comparison between original version to version 2019 and effect of an online support calculator.

Osman H, Yan J, Chan J, Munir J, Alrasheed S, Krishna S Can Urol Assoc J. 2021; 15(12):420-422.

PMID: 34171217 PMC: 8631836. DOI: 10.5489/cuaj.7369.

References

Zhang L, Tang M, Chen S, Lei X, Zhang X, Huan Y . A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol. 2017; 27(12):5204-5214. DOI: 10.1007/s00330-017-4843-7. View

Renard-Penna R, Mozer P, Cornud F, Barry-Delongchamps N, Bruguiere E, Portalez D . Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy. Radiology. 2015; 275(2):458-68. DOI: 10.1148/radiol.14140184. View

Cicchetti D, Sparrow S . Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am J Ment Defic. 1981; 86(2):127-37. View

Becker A, Cornelius A, Reiner C, Stocker D, Ulbrich E, Barth B . Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer. Eur J Radiol. 2017; 94:58-63. DOI: 10.1016/j.ejrad.2017.07.016. View

Futterer J, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A . Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol. 2015; 68(6):1045-53. DOI: 10.1016/j.eururo.2015.01.013. View

Donati O, Mazaheri Y, Afaq A, Vargas H, Zheng J, Moskowitz C . Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology. 2014; 271(1):143-52. DOI: 10.1148/radiol.13130973. View

Donati O, Chong D, Nanz D, Boss A, Froehlich J, Andres E . Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology. 2014; 270(2):454-63. DOI: 10.1148/radiol.13130819. View

Barrett T, Rajesh A, Rosenkrantz A, Choyke P, Turkbey B . PI-RADS version 2.1: one small step for prostate MRI. Clin Radiol. 2019; 74(11):841-852. DOI: 10.1016/j.crad.2019.05.019. View

Morris M, Saboury B, Bandla N, Toland C, Meenan C, Siegel E . Computer-Aided Reporting of Chest Radiographs: Efficient and Effective Screening in the Value-Based Imaging Era. J Digit Imaging. 2017; 30(5):589-594. PMC: 5603434. DOI: 10.1007/s10278-017-9952-y. View

10.

Kohestani K, Wallstrom J, Dehlfors N, Sponga O, Mansson M, Josefsson A . Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres. Scand J Urol. 2019; 53(5):304-311. PMC: 6935323. DOI: 10.1080/21681805.2019.1675757. View

11.

Mercaldo N, Lau K, Zhou X . Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2006; 26(10):2170-83. DOI: 10.1002/sim.2677. View

12.

Lin W, Muglia V, Silva G, Chodraui Filho S, Reis R, Westphalen A . Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems. Br J Radiol. 2016; 89(1062):20151056. PMC: 5258169. DOI: 10.1259/bjr.20151056. View

13.

Kasel-Seibert M, Lehmann T, Aschenbach R, Guettler F, Abubrig M, Grimm M . Assessment of PI-RADS v2 for the Detection of Prostate Cancer. Eur J Radiol. 2016; 85(4):726-31. DOI: 10.1016/j.ejrad.2016.01.011. View

14.

NiMhurchu E, OKelly F, Murphy I, Lavelle L, Collins C, Lennon G . Predictive value of PI-RADS classification in MRI-directed transrectal ultrasound guided prostate biopsy. Clin Radiol. 2016; 71(4):375-80. DOI: 10.1016/j.crad.2016.01.001. View

15.

Selnaes K, Heerschap A, Jensen L, Tessem M, Schweder G, Goa P . Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Invest Radiol. 2012; 47(11):624-33. DOI: 10.1097/RLI.0b013e318263f0fd. View

16.

Kirkham A, Haslam P, Keanie J, McCafferty I, Padhani A, Punwani S . Prostate MRI: who, when, and how? Report from a UK consensus meeting. Clin Radiol. 2013; 68(10):1016-23. DOI: 10.1016/j.crad.2013.03.030. View

17.

Donati O, Jung S, Vargas H, Gultekin D, Zheng J, Moskowitz C . Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?. Radiology. 2013; 268(2):440-50. PMC: 6940013. DOI: 10.1148/radiol.13122149. View

18.

Rosenkrantz A, Kim S, Lim R, Hindman N, Deng F, Babb J . Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology. 2013; 269(2):482-92. DOI: 10.1148/radiol.13122233. View

19.

Turkbey B, Rosenkrantz A, Haider M, Padhani A, Villeirs G, Macura K . Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019; 76(3):340-351. DOI: 10.1016/j.eururo.2019.02.033. View

20.

van Houdt P, Ghobadi G, Schoots I, Heijmink S, De Jong J, van der Poel H . Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions. J Magn Reson Imaging. 2019; 51(4):1235-1246. DOI: 10.1002/jmri.26933. View